Trial Profile
Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jan 2024
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Somatotropin deficiency
- Focus Therapeutic Use
- 18 Jan 2024 Status changed from active, no longer recruiting to completed.
- 08 Feb 2023 Planned End Date changed from 1 Jun 2023 to 1 Jun 2024.
- 08 Feb 2023 Planned primary completion date changed from 21 Dec 2022 to 21 Dec 2023.